The FDA’s official announcement about Sedasys was published in the Federal Register. The FDA intends to refer Ethicon’s petition for review of the FDA’s denial of premarket approval for review before an advisory committee.
Read the Federal Register notice on Sedasys System.
Read more about Sedasys:
–Johnson & Johnson and FDA Clash Over Rejection of Sedative
–ASA Responds to FDA’s Rejection of Johnson & Johnson’s Computer-Assisted Anesthesia Device
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
